Alimentary Pharmacology & Therapeutics

Message from the Editors
pp. 1-2(2)
Authors: Pounder, R. E.; Peterson, W. L.

Alimentary Pharmacology & Therapeutics
pp. 2-2(1)
Authors: Pounder, R. E.; Peterson, W. L.

Review article: altering the natural history of Crohn's disease - evidence for and against current therapies
pp. 3-12(10)
Authors: VERMEIRE, S.; VAN ASSCHE, G.; RUTGEERTS, P.

Review article: indeterminate colitis - definition, diagnosis and management
pp. 13-17(5)
Author: TREMAINE, W. J.

Systematic review: infliximab therapy in ulcerative colitis
pp. 19-37(19)
Authors: GISBERT, J. P.; GONZÁLEZ-LAMA, Y.; MATÉ, J.

Systematic review: rebound acid hypersecretion after therapy with proton pump inhibitors
pp. 39-46(8)
Authors: HUNFELD, N. G. M.; GEUS, W. P.; KUIPERS, E. J.

Meta-analysis: alvimopan vs. placebo in the treatment of post-operative ileus
pp. 47-57(11)
Authors: TAN, E. K.; CORNISH, J.; DARZI, A. W.; TEKKIS, P. P.

Long-term prognosis in Crohn's disease: an epidemiological study of patients diagnosed more than 20 years ago in Cardiff
pp. 59-65(7)
Authors: CANAVAN, C.; ABRAMS, K. R.; HAWTHORNE, B.; MAYBERRY, J. F.

Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: a prospective, non-randomized, parallel, controlled study
pp. 67-72(6)
Authors: YAMAMOTO, T.; NAKAHIGASHI, M.; UMEGAE, S.; KITAGAWA, T.; MATSUMOTO, K.

Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: a Danish nationwide cohort study
pp. 73-81(9)
Authors: LANGAGERGAARD, V.; PEDERSEN, L.; GISLUM, M.; NØRGARD, B.; SØRENSEN, H. T.

Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease?
pp. 83-91(9)
Authors: STOLTEY, J.; REEBA, H.; ULLAH, N.; SABHAIE, P.; GERSON, L.

Assessment of dietary nutrients that influence perception of intra-oesophageal acid reflux events in patients with gastro-oesophageal reflux disease
pp. 93-101(9)
Authors: SHAPIRO, M.; GREEN, C.; BAUTISTA, J. M.; DEKEL, R.; RISNER-ADLER, S.; WHITACRE, R.; GRAVER, E.; FASS, R.

Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment
pp. 103-109(7)
Authors: MINER, P. B.; ALLGOOD, L. D.; GRENDER, J. M.